Evidence map›Paper›PMID 31505629›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Pediatric Bacterial Meningitis Surveillance in the World Health Organization African Region Using the Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2011-2016.

Jason M Mwenda, Elizabeth Soda, Goitom Weldegebriel, Regis Katsande, Joseph Nsiari-Muzeyi Biey, Tieble Traore, Linda de Gouveia, Mignon du Plessis, Anne von Gottberg, Martin Antonio and 8 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Fc-MBL-modified FeMikrochimica acta · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jason M MwendaWorld Health Organization Regional Office for Africa, Brazzaville, Republic of Congo.
Elizabeth SodaEpidemic Intelligence Service, and, Atlanta, Georgia.
Goitom WeldegebrielWorld Health Organization (WHO) Regional Office for Africa, Intercountry Support Team, Harare, Zimbabwe.
Regis KatsandeWorld Health Organization Regional Office for Africa, Brazzaville, Republic of Congo.
Joseph Nsiari-Muzeyi BieyWHO Regional Office for Africa, Intercountry Support Team, Ouagadougou, Burkina Faso.
Tieble TraoreWorld Health Organization Regional Office for Africa, Brazzaville, Republic of Congo.
Linda de GouveiaNational Institute for Communicable Diseases, Johannesburg, South Africa.
Mignon du PlessisNational Institute for Communicable Diseases, Johannesburg, South Africa.
Anne von GottbergNational Institute for Communicable Diseases, Johannesburg, South Africa.
Martin AntonioMedical Research Council Unit, The Gambia at London School of Hygiene and Tropical Medicine, Banjul.
Brenda Kwambana-AdamsMedical Research Council Unit, The Gambia at London School of Hygiene and Tropical Medicine, Banjul.
Archibald WorwuiMedical Research Council Unit, The Gambia at London School of Hygiene and Tropical Medicine, Banjul.
Ryan GierkeDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Stephanie SchwartzDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Chris van BenedenDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Adam CohenWHO, Geneva, Switzerland.
Fatima SerhanWHO, Geneva, Switzerland.
Fernanda C LessaDivision of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundBacterial meningitis is a major cause of morbidity and mortality in sub-Saharan Africa. We analyzed data from the World Health Organization's (WHO) Invasive Bacterial Vaccine-preventable Diseases Surveillance Network (2011-2016) to describe the epidemiology of laboratory-confirmed Streptococcus pneumoniae (Spn), Neisseria meningitidis, and Haemophilus influenzae meningitis within the WHO African Region. We also evaluated declines in vaccine-type pneumococcal meningitis following pneumococcal conjugate vaccine (PCV) introduction.

methodsReports of meningitis in children <5 years old from sentinel surveillance hospitals in 26 countries were classified as suspected, probable, or confirmed. Confirmed meningitis cases were analyzed by age group and subregion (South-East and West-Central). We described case fatality ratios (CFRs), pathogen distribution, and annual changes in serotype and serogroup, including changes in vaccine-type Spn meningitis following PCV introduction.

resultsAmong 49 844 reported meningitis cases, 1670 (3.3%) were laboratory-confirmed. Spn (1007/1670 [60.3%]) was the most commonly detected pathogen; vaccine-type Spn meningitis cases declined over time. CFR was the highest for Spn meningitis: 12.9% (46/357) in the South-East subregion and 30.9% (89/288) in the West-Central subregion. Meningitis caused by N. meningitidis was more common in West-Central than South-East Africa (321/954 [33.6%] vs 110/716 [15.4%]; P < .0001). Haemophilus influenzae (232/1670 [13.9%]) was the least prevalent organism.

conclusionsSpn was the most common cause of pediatric bacterial meningitis in the African region even after reported cases declined following PCV introduction. Sustaining robust surveillance is essential to monitor changes in pathogen distribution and to inform and guide vaccination policies.

Indexed as

Sentinel SurveillanceWorld Health OrganizationAfrica, EasternChild, PreschoolFemaleHaemophilus influenzae type bHumansInfantMaleMeningitis, BacterialMortalityNeisseria meningitidisPneumococcal VaccinesPrevalenceSerogroupSouth AfricaPneumococcal VaccinesVaccines, Conjugatecase fatality ratiosPCVpediatric bacterial meningitispneumococcal conjugate vaccinesub-Saharan Africa

Identifiers

PMID31505629
PMCPMC6736400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.